BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Prognosis
14 results:

  • 1. Real-World Evaluation of the Management, Treatment Pathways and Outcome of Melanoma Patients with Target Therapies in Italy.
    Marcon IG; Valsecchi D; Durso L; Premoli E; Sangiorgi D; Perrone V; Catena L; Degli Esposti L
    Adv Ther; 2023 Sep; 40(9):3875-3895. PubMed ID: 37368101
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of prognostic alternative splicing signatures in uveal melanoma.
    Xie X; Zheng X; Xie T; Cai J; Yao Y
    Int Ophthalmol; 2021 Apr; 41(4):1347-1362. PubMed ID: 33479809
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Time to diagnosis of retinoblastoma in Latin America: A systematic review.
    Mattosinho CCS; Moura ATMS; Oigman G; Ferman SE; Grigorovski N
    Pediatr Hematol Oncol; 2019 Mar; 36(2):55-72. PubMed ID: 31014139
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Influence of functional variants Asp312Asn and Lys751Gln of Xeroderma Pigmentosum Group D (xpd) and Glutathione S-transferase Mu 1 (GSTM1) and Theta 1 (GSTT1) genes on cutaneous melanoma susceptibility and prognosis.
    Rinck-Junior JA; Torricelli C; Gomez GVB; Oliveira C; Moraes AM; Lourenço GJ; Lima CSP
    Exp Dermatol; 2019 May; 28(5):631-635. PubMed ID: 30883948
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.
    Boccard SG; Marand SV; Geraci S; Pycroft L; Berger FR; Pelletier LA
    Oncotarget; 2015 Oct; 6(30):29456-68. PubMed ID: 26336131
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Clinicopathological features and multivariate analysis of prognostic factors for patients with gastroenteropancreatic neuroendocrine tumors].
    Wang X; Song ZF; Yao WX; Pan CC; Xiang MF; Wang H
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1411-4. PubMed ID: 24025507
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Polymorphisms of nucleotide excision repair genes predict melanoma survival.
    Li C; Yin M; Wang LE; Amos CI; Zhu D; Lee JE; Gershenwald JE; Grimm EA; Wei Q
    J Invest Dermatol; 2013 Jul; 133(7):1813-21. PubMed ID: 23407396
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. DNA repair gene ERCC1 and xpd polymorphisms predict glioma susceptibility and prognosis.
    Chen DQ; Yao DX; Zhao HY; Yang SJ
    Asian Pac J Cancer Prev; 2012; 13(6):2791-4. PubMed ID: 22938460
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival.
    Azad AK; Bairati I; Samson E; Cheng D; Mirshams M; Qiu X; Savas S; Waldron J; Wang C; Goldstein D; Xu W; Meyer F; Liu G
    Clin Cancer Res; 2012 Jan; 18(1):196-206. PubMed ID: 22076708
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Comparison of MGMT and ERCC₂ expression in temozolomide for the treatment of malignant glioma drug resistance and their genetic relationship].
    Hou X; Zhao Y; Zheng YR; Wang JJ; Wu ZC; Sun JH
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(1):56-8. PubMed ID: 21418965
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. ERCC5 p.Asp1104His and ercc2 p.Lys751Gln polymorphisms are independent prognostic factors for the clinical course of melanoma.
    Schrama D; Scherer D; Schneider M; Zapatka M; Bröcker EB; Schadendorf D; Ugurel S; Kumar R; Becker JC
    J Invest Dermatol; 2011 Jun; 131(6):1280-90. PubMed ID: 21390047
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Expression analyses of 27 DNA repair genes in astrocytoma by TaqMan low-density array.
    Jiang Z; Hu J; Li X; Jiang Y; Zhou W; Lu D
    Neurosci Lett; 2006 Dec; 409(2):112-7. PubMed ID: 17034947
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. 1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas.
    Tarnawski R; Sokol M; Pieniazek P; Maciejewski B; Walecki J; Miszczyk L; Krupska T
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1271-6. PubMed ID: 11955739
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The costs of managing patients with malignant glioma at a neuro-oncology clinic.
    Latif AZ; Signorini D; Gregor A; Whittle IR
    Br J Neurosurg; 1998 Apr; 12(2):118-22. PubMed ID: 11013662
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.